drugset / Trial / NCT00257920
A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effects of Zemplar® Injection and Hectorol® Injection on intestinal calcium absorption in Chronic Kidney Disease Stage 5 subjects on hemodialysis.
Timeline
- Start
- 2006-06
- Primary completion
- 2008-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Doxercalciferol | Small molecule | 3.6 ug | — |
| Comparator | Paricalcitol | Other / unclassified | 6 ug | — |